WGU D027 OA Exam Advanced Pathopharmacological
Foundations | Tested Questions (Latest ) |
Verified Rationalized ANSWERS | 100% Guarantee Pass
Section 1: Cellular Biology, Immunity, & Inflammation
1. A 55-year-old male with a long history of smoking presents with a
persistent cough. Biopsy reveals that the normal ciliated columnar
epithelial cells of his bronchi have been replaced by stratified squamous
epithelial cells. What is this cellular adaptation called?
A) Dysplasia
B) Hyperplasia
C) Metaplasia
D) Anaplasia
Answer: C
Rationale: Metaplasia is the reversible replacement of one mature cell
type with another mature cell type. In smokers, the ciliated columnar
epithelium of the respiratory tract is replaced by stratified squamous
epithelium to better withstand the irritants in smoke, though this
results in a loss of mucociliary function.
2. Which of the following statements correctly describes the
pathophysiological mechanism of apoptosis?
A) It is a passive form of cell death resulting from severe ischemia and
toxins.
,B) It is an active, programmed process of cellular self-destruction that
eliminates damaged or aging cells.
C) It always triggers a severe inflammatory response.
D) It results in cellular swelling and rupture of the cell membrane.
Answer: B
Rationale: Apoptosis is "programmed cell death." It is an active, ATP-
dependent process that removes unwanted or damaged cells without
eliciting an inflammatory response. In contrast, necrosis (A and D) is
passive, pathologic cell death that causes inflammation.
3. A patient is diagnosed with Systemic Lupus Erythematosus (SLE).
Which of the following best describes the underlying immunologic
mechanism of this disease?
A) Type I hypersensitivity (IgE-mediated)
B) Type II hypersensitivity (cytotoxic)
C) Type III hypersensitivity (immune complex-mediated)
D) Type IV hypersensitivity (delayed, cell-mediated)
Answer: C
Rationale: SLE is a systemic autoimmune disease characterized by the
formation of antigen-antibody (immune) complexes that deposit in
various tissues (such as the glomeruli, skin, and joints), triggering
complement activation and widespread inflammation (Type III
hypersensitivity).
,4. During the acute inflammatory response, which chemical mediator is
primarily responsible for causing vasodilation and increasing vascular
permeability at the site of injury?
A) Histamine
B) Interleukin-1
C) Leukotriene B4
D) Prostacyclin
Answer: A
Rationale: Histamine, released from mast cells, is one of the first
mediators of acute inflammation. It causes transient vasodilation
(redness and heat) and increased vascular permeability (edema),
allowing leukocytes and proteins to enter the tissue.
5. A 40-year-old female presents with fatigue, weight gain, and cold
intolerance. Lab tests reveal elevated TSH and low T4. Which of the
following best describes the pathophysiology of her condition?
A) Primary hyperthyroidism
B) Secondary hypothyroidism
C) Primary hypothyroidism
D) Tertiary hypothyroidism
Answer: C
Rationale: Elevated TSH with low T4 indicates primary hypothyroidism
(e.g., Hashimoto's thyroiditis). The thyroid gland is failing to produce T4
, (low T4), causing the pituitary to secrete excess TSH to attempt to
stimulate the failing thyroid gland.
Section 2: Neurological & Musculoskeletal Disorders
6. A patient with Parkinson's disease is prescribed levodopa/carbidopa.
What is the primary pharmacological rationale for combining these two
drugs?
A) Carbidopa acts as a dopamine agonist to enhance the effect of
levodopa.
B) Carbidopa prevents the breakdown of levodopa in the peripheral
nervous system, allowing more to cross the blood-brain barrier.
C) Carbidopa reduces the anticholinergic side effects of levodopa.
D) Carbidopa enhances the absorption of levodopa in the
gastrointestinal tract.
Answer: B
Rationale: Levodopa is the precursor to dopamine and crosses the
blood-brain barrier. Carbidopa is a peripheral decarboxylase inhibitor.
By blocking the conversion of levodopa to dopamine in the periphery,
more levodopa is available to cross into the brain, reducing required
dosage and peripheral side effects (like nausea and cardiac
arrhythmias).
7. Which of the following pathophysiological findings is characteristic of
Multiple Sclerosis (MS)?
Foundations | Tested Questions (Latest ) |
Verified Rationalized ANSWERS | 100% Guarantee Pass
Section 1: Cellular Biology, Immunity, & Inflammation
1. A 55-year-old male with a long history of smoking presents with a
persistent cough. Biopsy reveals that the normal ciliated columnar
epithelial cells of his bronchi have been replaced by stratified squamous
epithelial cells. What is this cellular adaptation called?
A) Dysplasia
B) Hyperplasia
C) Metaplasia
D) Anaplasia
Answer: C
Rationale: Metaplasia is the reversible replacement of one mature cell
type with another mature cell type. In smokers, the ciliated columnar
epithelium of the respiratory tract is replaced by stratified squamous
epithelium to better withstand the irritants in smoke, though this
results in a loss of mucociliary function.
2. Which of the following statements correctly describes the
pathophysiological mechanism of apoptosis?
A) It is a passive form of cell death resulting from severe ischemia and
toxins.
,B) It is an active, programmed process of cellular self-destruction that
eliminates damaged or aging cells.
C) It always triggers a severe inflammatory response.
D) It results in cellular swelling and rupture of the cell membrane.
Answer: B
Rationale: Apoptosis is "programmed cell death." It is an active, ATP-
dependent process that removes unwanted or damaged cells without
eliciting an inflammatory response. In contrast, necrosis (A and D) is
passive, pathologic cell death that causes inflammation.
3. A patient is diagnosed with Systemic Lupus Erythematosus (SLE).
Which of the following best describes the underlying immunologic
mechanism of this disease?
A) Type I hypersensitivity (IgE-mediated)
B) Type II hypersensitivity (cytotoxic)
C) Type III hypersensitivity (immune complex-mediated)
D) Type IV hypersensitivity (delayed, cell-mediated)
Answer: C
Rationale: SLE is a systemic autoimmune disease characterized by the
formation of antigen-antibody (immune) complexes that deposit in
various tissues (such as the glomeruli, skin, and joints), triggering
complement activation and widespread inflammation (Type III
hypersensitivity).
,4. During the acute inflammatory response, which chemical mediator is
primarily responsible for causing vasodilation and increasing vascular
permeability at the site of injury?
A) Histamine
B) Interleukin-1
C) Leukotriene B4
D) Prostacyclin
Answer: A
Rationale: Histamine, released from mast cells, is one of the first
mediators of acute inflammation. It causes transient vasodilation
(redness and heat) and increased vascular permeability (edema),
allowing leukocytes and proteins to enter the tissue.
5. A 40-year-old female presents with fatigue, weight gain, and cold
intolerance. Lab tests reveal elevated TSH and low T4. Which of the
following best describes the pathophysiology of her condition?
A) Primary hyperthyroidism
B) Secondary hypothyroidism
C) Primary hypothyroidism
D) Tertiary hypothyroidism
Answer: C
Rationale: Elevated TSH with low T4 indicates primary hypothyroidism
(e.g., Hashimoto's thyroiditis). The thyroid gland is failing to produce T4
, (low T4), causing the pituitary to secrete excess TSH to attempt to
stimulate the failing thyroid gland.
Section 2: Neurological & Musculoskeletal Disorders
6. A patient with Parkinson's disease is prescribed levodopa/carbidopa.
What is the primary pharmacological rationale for combining these two
drugs?
A) Carbidopa acts as a dopamine agonist to enhance the effect of
levodopa.
B) Carbidopa prevents the breakdown of levodopa in the peripheral
nervous system, allowing more to cross the blood-brain barrier.
C) Carbidopa reduces the anticholinergic side effects of levodopa.
D) Carbidopa enhances the absorption of levodopa in the
gastrointestinal tract.
Answer: B
Rationale: Levodopa is the precursor to dopamine and crosses the
blood-brain barrier. Carbidopa is a peripheral decarboxylase inhibitor.
By blocking the conversion of levodopa to dopamine in the periphery,
more levodopa is available to cross into the brain, reducing required
dosage and peripheral side effects (like nausea and cardiac
arrhythmias).
7. Which of the following pathophysiological findings is characteristic of
Multiple Sclerosis (MS)?
